Catheter Ablation in Patients With End-Stage Heart Failure and Atrial Fibrillation: Two-Year Follow-Up of the CASTLE-HTx Trial.
Sohns C, Moersdorf M, Marrouche NF, Bergau L, Costard-Jaeckle A, Crijns HJGM, Fox H, Hindricks G, Dagres N, Sossalla S, Schramm R, Fink T, Hamriti ME, Sciacca V, Didenko M, Konietschke F, Rudolph V, Gummert J, Tijssen JGP, Sommer P; CASTLE HTx Investigators.
Sohns C, et al. Among authors: fox h.
Circulation. 2024 Dec 3;150(23):1904-1906. doi: 10.1161/CIRCULATIONAHA.124.071517. Epub 2024 Aug 30.
Circulation. 2024.
PMID: 39213004
No abstract available.